IBio, Mesoblast, Kodiak Sciences Among Healthcare Movers
BeyondSpring Says First Patient Dosed in Phase 2 Trial of Lung Cancer Combination Treatment
BeyondSpring (BYSI) said Monday that the first patient has been dosed in a phase 2 investigator-initiated trial of pembrolizumab, plinabulin plus etoposide/platinum for first-line extensive-stage smal
BeyondSpring Announces First Patient Dosed With Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BeyondSpring Inc. (NASDAQ: BYSI) today announced that the first patient has been dosed in a Phase 2 investigator-initiated trial (IIT) with Pembrolizumab, Plinabulin, BeyondSpring's lead asset, plus Etoposide/Platinum (EP) for first-line (1L) Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) [NCT05745350].
BeyondSpring Announces Executive Leadership Change
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersPsyence Biomedical (NASDAQ:PBM) stock moved upwards by 35.3% to $1.38 during Thursday's regular session. The market value of their outstanding shares is at $18.4 million. ZyVersa Therapeutics (
BeyondSpring, EnVVeno Medical, Aptorum Group Among Healthcare Movers
BYSI, PHUN and DTSS Among Pre-market Losers
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNKGen Biotech (NASDAQ:NKGN) shares increased by 69.4% to $1.46 during Wednesday's pre-market session. The market value of their outstanding shares is at $31.9 million. Creative Medical Tech (NA
Top Premarket Decliners
Entravision Communications (EVC) shares slumped 50% Wednesday premarket after the company posted a wider Q4 loss. Thor Industries (THO) shares fell 17% after reporting weaker fiscal Q2 financial resul
Individual Investors Who Hold 59% of BeyondSpring Inc. (NASDAQ:BYSI) Gained 125%, Insiders Profited as Well
Key Insights Significant control over BeyondSpring by individual investors implies that the general public has more power to influence management and governance-related decisions 41% of the business
EYEN, BYSI and FENG Among Mid-day Movers
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersSunshine Biopharma (NASDAQ:SBFM) stock rose 142.3% to $0.11 during Tuesday's regular session. The company's market cap stands at $5.9 million. Ocean Biomedical (NASDAQ:OCEA) shares rose 54.65%
BeyondSpring Regains Nasdaq Compliance as Price Surges Above $1
BeyondSpring Regains Compliance With Nasdaq Minimum Bid Price And Periodic Filing Requirements
BeyondSpring Inc. (NASDAQ:BYSI) ("BeyondSpring" or the "Company"), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and develo
BeyondSpring Regains Compliance With Nasdaq Minimum Bid Price and Periodic Filing Requirements
FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) ("BeyondSpring" or the "Company"), a global clinical-stage biopharmaceutical company focused on using a groundbrea
BeyondSpring Disclosed On January 10, 2024, The Arbitral Tribunal At China International Economic And Trade Arbitration Committee Issued A Final Award, Denying All Claims Made By Hengrui
https://www.sec.gov/Archives/edgar/data/1677940/000114036124002349/ef20018876_6k.htm
BeyondSpring Gets Nasdaq Delinquency Notice
BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K
NEW YORK, January 10, 2024 – BeyondSpring Inc. (NASDAQ: BYSI) ("BeyondSpring" or the "Company"), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform
BeyondSpring Receives Notification From Nasdaq for Breaching Minimum Bid Price Requirements
BeyondSpring (BYSI) reported late Monday non-compliance of its shares with the minimum closing bid price of $1.00 per share Nasdaq listing rule. The company said the closing bid price was below the th
Promising Potential of Plinabulin Reinforces Buy Recommendation for Beyondspring
No Data